Analysts Offer Insights on Materials Companies: NioCorp Developments (NB), Amrize Ltd (AMRZ) and Nutrien (NTR)
Companies in the Materials sector have received a lot of coverage today as analysts weigh in on NioCorp Developments (NB), Amrize Ltd (AMRZ) and Nutrien (NTR).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NioCorp Developments (NB)
In a report released today, Neal Dingmann from William Blair maintained a Buy rating on NioCorp Developments. The company’s shares closed last Tuesday at $4.99.
According to TipRanks.com, Dingmann is a 3-star analyst with an average return of
Currently, the analyst consensus on NioCorp Developments is a Strong Buy with an average price target of $12.50, which is a 138.1% upside from current levels. In a report issued on April 9, H.C. Wainwright also reiterated a Buy rating on the stock with a $10.00 price target.
See today’s best-performing stocks on TipRanks >>
Amrize Ltd (AMRZ)
According to TipRanks.com, Zhang is ranked #7041 out of 12179 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Amrize Ltd with a $65.45 average price target, which is a 9.4% upside from current levels. In a report issued on March 31, TipRanks – Anthropic also reiterated a Hold rating on the stock with a $58.00 price target.
Nutrien (NTR)
In a report released yesterday, Duffy Fischer from Goldman Sachs maintained a Sell rating on Nutrien, with a price target of $76.00. The company’s shares closed last Tuesday at $73.62.
According to TipRanks.com, Fischer is a 5-star analyst with an average return of
Currently, the analyst consensus on Nutrien is a Moderate Buy with an average price target of $81.40.
Read More on NB:
Disclaimer & DisclosureReport an Issue
- NioCorp management to meet with Oppenheimer
- NioCorp: Traxys Offtake Framework and Equity Investment De-Risk Demand, Strengthen Financing Path to Support Buy Rating
- NioCorp price target lowered to $10 from $11.25 at H.C. Wainwright
- NioCorp: Advancing Elk Creek Development and De-Risking Funding Supports Buy Rating Despite Dilution-Driven Target Cut
- Australia’s Jindalee Plans U.S. IPO for Lithium Developer in $571M SPAC Deal
